Top 1000 Biomanufacturing Facilities - Knowing where key biomanufacturing facilities are located around the world is essential for decision-making. - BioPharm International

ADVERTISEMENT

Top 1000 Biomanufacturing Facilities
Knowing where key biomanufacturing facilities are located around the world is essential for decision-making.


BioPharm International
Volume 24, Issue 6, pp. 27-29

Some in the industry find it hard to imagine that there are 1000 biomanufacturers worldwide. But our research, reports, and studies have shown that in China and India alone the number of qualified facilities has grown more than 20% in the past three years to their current number of 91 and 99, respectively (see Table I). To create the BioPlan BioFacility Index and rank biomanufacturers, we analyzed overall fixed capacity, manufacturing-related employment, and number of commercial and clinical products. The result is an indexed ranking based on these factors. Shortcomings in this methodology include: difficulty in establishing equivalence between capacity for, say, a monoclonal versus microbial, versus vaccine production; questions regarding which functions are "manufacturing related"; weight to be applied to each factor; and the need to monitor each factor regularly to ensure up-to-date ranking. Prior efforts to benchmark manufacturing have generally failed because managing thousands of data points, year after year, becomes virtually impossible. For this effort, we are making use of the industry's own knowledge. Our analysis uses publicly available information that we have amassed over decades. In addition, we have recruited hundreds of participants to maintain the listing. But most uniquely, to keep the data accurate, we have implemented a "Wiki" approach whereby industry is able to contribute public knowledge.

In addition, BioPlan will pass proposed changes to the database through our review panel to ensure accuracy and consistency of any updates.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

EMA Works to Speed Up Ebola Treatment
October 20, 2014
Amgen Sues Sanofi and Regeneron over Patent for mAb Targeting PCSK9
October 20, 2014
Harnessing the Power of Modified T Cells to Treat Cancer
October 17, 2014
BioReliance Introduces New Predictive Assays
October 17, 2014
Lilly to Close Manufacturing Facility in Puerto Rico
October 17, 2014
Author Guidelines
Source: BioPharm International,
Click here